Request Demo
Last update 05 Dec 2025
Anti-CD19/CD20 CAR-T cell therapy (PersonGen BioTherapeutics)
Last update 05 Dec 2025
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms Autologous CD19/CD20CART cells |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), Gene transference(Gene transference) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Anti-CD19/CD20 CAR-T cell therapy (PersonGen BioTherapeutics)NCT04700319
CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies
100 Clinical Results associated with Anti-CD19/CD20 CAR-T cell therapy (PersonGen BioTherapeutics)
Login to view more data
100 Translational Medicine associated with Anti-CD19/CD20 CAR-T cell therapy (PersonGen BioTherapeutics)
Login to view more data
100 Patents (Medical) associated with Anti-CD19/CD20 CAR-T cell therapy (PersonGen BioTherapeutics)
Login to view more data
100 Deals associated with Anti-CD19/CD20 CAR-T cell therapy (PersonGen BioTherapeutics)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Lymphoblastic Leukemia | Phase 1 | China | 19 Apr 2019 | |
| CD19 Positive Lymphoma | Phase 1 | China | 19 Apr 2019 | |
| CD20 positive Hematologic Neoplasms | Phase 1 | China | 19 Apr 2019 | |
| Chronic Lymphocytic Leukemia | Phase 1 | China | 19 Apr 2019 | |
| Non-Hodgkin Lymphoma | Phase 1 | China | 19 Apr 2019 | |
| Recurrent Hematologic Malignancy | Phase 1 | China | 19 Apr 2019 | |
| Refractory Hematologic Malignancy | Phase 1 | China | 19 Apr 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free